Sea You at Fetch Long Beach
News|Videos|September 16, 2023

Breakthroughs with liquid biopsy testing

Nashville hosting veterinary conference

Andi Flory, DVM, DACVIM (Oncology), gives an overview of liquid biopsy testing and when to use it

In a dvm360 interview, Andi Flory, DVM, DACVIM (Oncology), co-founder and chief medical officer of PetDx, described OncoK9, a multi-cancer early detection test for dogs done with a simple blood draw. Developed by PetDx, Flory explains how it works and how it can be used for veterinary patients.

The following is a partial transcript of the video.

Andi Flory, DVM, DACVIM (Oncology): We developed a test called OncoK9. This is a test that uses advanced technology called next generation sequencing and it's looking for tumor DNA. So, it's looking for little bits of DNA that circulate in the blood, and they're coming from cancer cells. And we can tell that these are coming from cancer cells, because these little bits of DNA have mutations in them. So, they have these genomic alterations. And that's how we know that they're unique, and they're different. So, this can alert us to the presence of cancer in the body.


Related to this article

Q&A: Caregiver burden can begin early in pet illness. Are veterinary teams equipped to support clients, and how can veterinary social workers help both parties?
Caroline Cox, LSW, MSW, and Erika Krick, VMD, DACVIM (Oncology), discuss the role of veterinary social workers in supporting clients, communicating with veterinary teams, and helping practices address the human side of veterinary care in this Q&A from an interview at the 2026 Fetch National Harbor Veterinary Conference.
Laverdia now available for purchase for dogs with lymphoma
Verdinexor tablets are now available for dogs with lymphoma after receiving full FDA approval earlier this year, offering an at-home treatment option given twice weekly and showing a longer time to disease progression than the control in a field study.